FindMyKOL
Clinical trialNCT04667416UnknownPhase 2Interventional

Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities

SponsorAmnio Technology, LLCEnrollment82Chronic Ulcer of Lower Extremity
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to assess the safety and preliminary efficacy of PalinGen® Flow for the treatment of chronic ulcers of the lower legs and feet.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Center for Clinical Research

    Carmichael, California, United States

  • Center for Clinical Research

    Castro Valley, California, United States

  • Limb Preservation Platform

    Fresno, California, United States

  • Center for Clinical Research

    San Francisco, California, United States

  • Ild Research Center

    Vista, California, United States

  • Acclaim Bone & Joint Institute and Plastic Surgery

    Fort Worth, Texas, United States

  • Futuro Clinical Trials

    McAllen, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PalinGen Flow Amniotic Tissue Allograft
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Jan 2021
Primary completion
31 Mar 2024
Completion
31 Jan 2025
Last update posted
20 Mar 2024
Registered enrollment
82
Registry id
NCT04667416

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.